世界のシグナル伝達阻害剤市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Signal Transduction Inhibitors Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z5236
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、97ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、シグナル伝達阻害剤のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ダサチニブ、エルロチニブ、ゲフィチニブ、イマチニブ、ラパチニブ、ニロチニブ、パゾパニブ、ソラフェニブ、スニチニブ）、用途別市場規模（病院薬局、小売薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・シグナル伝達阻害剤の市場動向
・企業の競争状況、市場シェア
・シグナル伝達阻害剤の種類別市場規模（ダサチニブ、エルロチニブ、ゲフィチニブ、イマチニブ、ラパチニブ、ニロチニブ、パゾパニブ、ソラフェニブ、スニチニブ）
・シグナル伝達阻害剤の用途別市場規模（病院薬局、小売薬局）
・シグナル伝達阻害剤の北米市場規模2016-2027（アメリカ、カナダ）
・シグナル伝達阻害剤のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・シグナル伝達阻害剤のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・シグナル伝達阻害剤の中南米市場規模2016-2027（メキシコ、ブラジル）
・シグナル伝達阻害剤の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Bristol-Myers Squibb、Roche、AstraZeneca、GSK、Novartis、Amgen、Pfizer）
・結論

Signal transduction inhibitors are drugs that may prevent the ability of cancer cells to multiply quickly and invade other tissues.
Growing need for effective cancer diagnostics and innovative therapies for cancer treatment are expected to be the major factors driving the signal transduction inhibitors market.

Market Analysis and Insights: Global Signal Transduction Inhibitors Market
The global Signal Transduction Inhibitors market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Signal Transduction Inhibitors market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Signal Transduction Inhibitors market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Signal Transduction Inhibitors market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Signal Transduction Inhibitors market.

Global Signal Transduction Inhibitors Scope and Market Size
Signal Transduction Inhibitors market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Signal Transduction Inhibitors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Dasatinib
Erlotinib
Gefitinib
Imatinib
Lapatinib
Nilotinib
Pazopanib
Sorafenib
Sunitinib

Segment by Application
Hospital Pharmacies
Retail Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Bristol-Myers Squibb
Roche
AstraZeneca
GSK
Novartis
Amgen
Pfizer

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Signal Transduction Inhibitors Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Dasatinib
1.2.3 Erlotinib
1.2.4 Gefitinib
1.2.5 Imatinib
1.2.6 Lapatinib
1.2.7 Nilotinib
1.2.8 Pazopanib
1.2.9 Sorafenib
1.2.10 Sunitinib
1.3 Market by Application
1.3.1 Global Signal Transduction Inhibitors Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Signal Transduction Inhibitors Market Perspective (2016-2027)
2.2 Signal Transduction Inhibitors Growth Trends by Regions
2.2.1 Signal Transduction Inhibitors Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Signal Transduction Inhibitors Historic Market Share by Regions (2016-2021)
2.2.3 Signal Transduction Inhibitors Forecasted Market Size by Regions (2022-2027)
2.3 Signal Transduction Inhibitors Industry Dynamic
2.3.1 Signal Transduction Inhibitors Market Trends
2.3.2 Signal Transduction Inhibitors Market Drivers
2.3.3 Signal Transduction Inhibitors Market Challenges
2.3.4 Signal Transduction Inhibitors Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Signal Transduction Inhibitors Players by Revenue
3.1.1 Global Top Signal Transduction Inhibitors Players by Revenue (2016-2021)
3.1.2 Global Signal Transduction Inhibitors Revenue Market Share by Players (2016-2021)
3.2 Global Signal Transduction Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Signal Transduction Inhibitors Revenue
3.4 Global Signal Transduction Inhibitors Market Concentration Ratio
3.4.1 Global Signal Transduction Inhibitors Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Signal Transduction Inhibitors Revenue in 2020
3.5 Signal Transduction Inhibitors Key Players Head office and Area Served
3.6 Key Players Signal Transduction Inhibitors Product Solution and Service
3.7 Date of Enter into Signal Transduction Inhibitors Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Signal Transduction Inhibitors Breakdown Data by Type
4.1 Global Signal Transduction Inhibitors Historic Market Size by Type (2016-2021)
4.2 Global Signal Transduction Inhibitors Forecasted Market Size by Type (2022-2027)

5 Signal Transduction Inhibitors Breakdown Data by Application
5.1 Global Signal Transduction Inhibitors Historic Market Size by Application (2016-2021)
5.2 Global Signal Transduction Inhibitors Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Signal Transduction Inhibitors Market Size (2016-2027)
6.2 North America Signal Transduction Inhibitors Market Size by Type
6.2.1 North America Signal Transduction Inhibitors Market Size by Type (2016-2021)
6.2.2 North America Signal Transduction Inhibitors Market Size by Type (2022-2027)
6.2.3 North America Signal Transduction Inhibitors Market Size by Type (2016-2027)
6.3 North America Signal Transduction Inhibitors Market Size by Application
6.3.1 North America Signal Transduction Inhibitors Market Size by Application (2016-2021)
6.3.2 North America Signal Transduction Inhibitors Market Size by Application (2022-2027)
6.3.3 North America Signal Transduction Inhibitors Market Size by Application (2016-2027)
6.4 North America Signal Transduction Inhibitors Market Size by Country
6.4.1 North America Signal Transduction Inhibitors Market Size by Country (2016-2021)
6.4.2 North America Signal Transduction Inhibitors Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Signal Transduction Inhibitors Market Size (2016-2027)
7.2 Europe Signal Transduction Inhibitors Market Size by Type
7.2.1 Europe Signal Transduction Inhibitors Market Size by Type (2016-2021)
7.2.2 Europe Signal Transduction Inhibitors Market Size by Type (2022-2027)
7.2.3 Europe Signal Transduction Inhibitors Market Size by Type (2016-2027)
7.3 Europe Signal Transduction Inhibitors Market Size by Application
7.3.1 Europe Signal Transduction Inhibitors Market Size by Application (2016-2021)
7.3.2 Europe Signal Transduction Inhibitors Market Size by Application (2022-2027)
7.3.3 Europe Signal Transduction Inhibitors Market Size by Application (2016-2027)
7.4 Europe Signal Transduction Inhibitors Market Size by Country
7.4.1 Europe Signal Transduction Inhibitors Market Size by Country (2016-2021)
7.4.2 Europe Signal Transduction Inhibitors Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Signal Transduction Inhibitors Market Size (2016-2027)
8.2 Asia-Pacific Signal Transduction Inhibitors Market Size by Type
8.2.1 Asia-Pacific Signal Transduction Inhibitors Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Signal Transduction Inhibitors Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Signal Transduction Inhibitors Market Size by Type (2016-2027)
8.3 Asia-Pacific Signal Transduction Inhibitors Market Size by Application
8.3.1 Asia-Pacific Signal Transduction Inhibitors Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Signal Transduction Inhibitors Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Signal Transduction Inhibitors Market Size by Application (2016-2027)
8.4 Asia-Pacific Signal Transduction Inhibitors Market Size by Region
8.4.1 Asia-Pacific Signal Transduction Inhibitors Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Signal Transduction Inhibitors Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Signal Transduction Inhibitors Market Size (2016-2027)
9.2 Latin America Signal Transduction Inhibitors Market Size by Type
9.2.1 Latin America Signal Transduction Inhibitors Market Size by Type (2016-2021)
9.2.2 Latin America Signal Transduction Inhibitors Market Size by Type (2022-2027)
9.2.3 Latin America Signal Transduction Inhibitors Market Size by Type (2016-2027)
9.3 Latin America Signal Transduction Inhibitors Market Size by Application
9.3.1 Latin America Signal Transduction Inhibitors Market Size by Application (2016-2021)
9.3.2 Latin America Signal Transduction Inhibitors Market Size by Application (2022-2027)
9.3.3 Latin America Signal Transduction Inhibitors Market Size by Application (2016-2027)
9.4 Latin America Signal Transduction Inhibitors Market Size by Country
9.4.1 Latin America Signal Transduction Inhibitors Market Size by Country (2016-2021)
9.4.2 Latin America Signal Transduction Inhibitors Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Signal Transduction Inhibitors Market Size (2016-2027)
10.2 Middle East & Africa Signal Transduction Inhibitors Market Size by Type
10.2.1 Middle East & Africa Signal Transduction Inhibitors Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Signal Transduction Inhibitors Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Signal Transduction Inhibitors Market Size by Type (2016-2027)
10.3 Middle East & Africa Signal Transduction Inhibitors Market Size by Application
10.3.1 Middle East & Africa Signal Transduction Inhibitors Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Signal Transduction Inhibitors Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Signal Transduction Inhibitors Market Size by Application (2016-2027)
10.4 Middle East & Africa Signal Transduction Inhibitors Market Size by Country
10.4.1 Middle East & Africa Signal Transduction Inhibitors Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Signal Transduction Inhibitors Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Bristol-Myers Squibb
11.1.1 Bristol-Myers Squibb Company Details
11.1.2 Bristol-Myers Squibb Business Overview
11.1.3 Bristol-Myers Squibb Signal Transduction Inhibitors Introduction
11.1.4 Bristol-Myers Squibb Revenue in Signal Transduction Inhibitors Business (2016-2021)
11.1.5 Bristol-Myers Squibb Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Signal Transduction Inhibitors Introduction
11.2.4 Roche Revenue in Signal Transduction Inhibitors Business (2016-2021)
11.2.5 Roche Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Details
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Signal Transduction Inhibitors Introduction
11.3.4 AstraZeneca Revenue in Signal Transduction Inhibitors Business (2016-2021)
11.3.5 AstraZeneca Recent Development
11.4 GSK
11.4.1 GSK Company Details
11.4.2 GSK Business Overview
11.4.3 GSK Signal Transduction Inhibitors Introduction
11.4.4 GSK Revenue in Signal Transduction Inhibitors Business (2016-2021)
11.4.5 GSK Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Signal Transduction Inhibitors Introduction
11.5.4 Novartis Revenue in Signal Transduction Inhibitors Business (2016-2021)
11.5.5 Novartis Recent Development
11.6 Amgen
11.6.1 Amgen Company Details
11.6.2 Amgen Business Overview
11.6.3 Amgen Signal Transduction Inhibitors Introduction
11.6.4 Amgen Revenue in Signal Transduction Inhibitors Business (2016-2021)
11.6.5 Amgen Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Signal Transduction Inhibitors Introduction
11.7.4 Pfizer Revenue in Signal Transduction Inhibitors Business (2016-2021)
11.7.5 Pfizer Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Signal Transduction Inhibitors Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Dasatinib
Table 3. Key Players of Erlotinib
Table 4. Key Players of Gefitinib
Table 5. Key Players of Imatinib
Table 6. Key Players of Lapatinib
Table 7. Key Players of Nilotinib
Table 8. Key Players of Pazopanib
Table 9. Key Players of Sorafenib
Table 10. Key Players of Sunitinib
Table 11. Global Signal Transduction Inhibitors Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 12. Global Signal Transduction Inhibitors Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 13. Global Signal Transduction Inhibitors Market Size by Regions (2016-2021) & (US$ Million)
Table 14. Global Signal Transduction Inhibitors Market Share by Regions (2016-2021)
Table 15. Global Signal Transduction Inhibitors Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 16. Global Signal Transduction Inhibitors Market Share by Regions (2022-2027)
Table 17. Signal Transduction Inhibitors Market Trends
Table 18. Signal Transduction Inhibitors Market Drivers
Table 19. Signal Transduction Inhibitors Market Challenges
Table 20. Signal Transduction Inhibitors Market Restraints
Table 21. Global Signal Transduction Inhibitors Revenue by Players (2016-2021) & (US$ Million)
Table 22. Global Signal Transduction Inhibitors Market Share by Players (2016-2021)
Table 23. Global Top Signal Transduction Inhibitors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Signal Transduction Inhibitors as of 2020)
Table 24. Ranking of Global Top Signal Transduction Inhibitors Companies by Revenue (US$ Million) in 2020
Table 25. Global 5 Largest Players Market Share by Signal Transduction Inhibitors Revenue (CR5 and HHI) & (2016-2021)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players Signal Transduction Inhibitors Product Solution and Service
Table 28. Date of Enter into Signal Transduction Inhibitors Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Signal Transduction Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 31. Global Signal Transduction Inhibitors Revenue Market Share by Type (2016-2021)
Table 32. Global Signal Transduction Inhibitors Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 33. Global Signal Transduction Inhibitors Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 34. Global Signal Transduction Inhibitors Market Size Share by Application (2016-2021) & (US$ Million)
Table 35. Global Signal Transduction Inhibitors Revenue Market Share by Application (2016-2021)
Table 36. Global Signal Transduction Inhibitors Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 37. Global Signal Transduction Inhibitors Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 38. North America Signal Transduction Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 39. North America Signal Transduction Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 40. North America Signal Transduction Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 41. North America Signal Transduction Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 42. North America Signal Transduction Inhibitors Market Size by Country (2016-2021) & (US$ Million)
Table 43. North America Signal Transduction Inhibitors Market Size by Country (2022-2027) & (US$ Million)
Table 44. Europe Signal Transduction Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 45. Europe Signal Transduction Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 46. Europe Signal Transduction Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 47. Europe Signal Transduction Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 48. Europe Signal Transduction Inhibitors Market Size by Country (2016-2021) & (US$ Million)
Table 49. Europe Signal Transduction Inhibitors Market Size by Country (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Signal Transduction Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 51. Asia-Pacific Signal Transduction Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Signal Transduction Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 53. Asia-Pacific Signal Transduction Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 54. Asia-Pacific Signal Transduction Inhibitors Market Size by Region (2016-2021) & (US$ Million)
Table 55. Asia-Pacific Signal Transduction Inhibitors Market Size by Region (2022-2027) & (US$ Million)
Table 56. Latin America Signal Transduction Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 57. Latin America Signal Transduction Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 58. Latin America Signal Transduction Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 59. Latin America Signal Transduction Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 60. Latin America Signal Transduction Inhibitors Market Size by Country (2016-2021) & (US$ Million)
Table 61. Latin America Signal Transduction Inhibitors Market Size by Country (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Signal Transduction Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 63. Middle East & Africa Signal Transduction Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Signal Transduction Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 65. Middle East & Africa Signal Transduction Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 66. Middle East & Africa Signal Transduction Inhibitors Market Size by Country (2016-2021) & (US$ Million)
Table 67. Middle East & Africa Signal Transduction Inhibitors Market Size by Country (2022-2027) & (US$ Million)
Table 68. Bristol-Myers Squibb Company Details
Table 69. Bristol-Myers Squibb Business Overview
Table 70. Bristol-Myers Squibb Signal Transduction Inhibitors Product
Table 71. Bristol-Myers Squibb Revenue in Signal Transduction Inhibitors Business (2016-2021) & (US$ Million)
Table 72. Bristol-Myers Squibb Recent Development
Table 73. Roche Company Details
Table 74. Roche Business Overview
Table 75. Roche Signal Transduction Inhibitors Product
Table 76. Roche Revenue in Signal Transduction Inhibitors Business (2016-2021) & (US$ Million)
Table 77. Roche Recent Development
Table 78. AstraZeneca Company Details
Table 79. AstraZeneca Business Overview
Table 80. AstraZeneca Signal Transduction Inhibitors Product
Table 81. AstraZeneca Revenue in Signal Transduction Inhibitors Business (2016-2021) & (US$ Million)
Table 82. AstraZeneca Recent Development
Table 83. GSK Company Details
Table 84. GSK Business Overview
Table 85. GSK Signal Transduction Inhibitors Product
Table 86. GSK Revenue in Signal Transduction Inhibitors Business (2016-2021) & (US$ Million)
Table 87. GSK Recent Development
Table 88. Novartis Company Details
Table 89. Novartis Business Overview
Table 90. Novartis Signal Transduction Inhibitors Product
Table 91. Novartis Revenue in Signal Transduction Inhibitors Business (2016-2021) & (US$ Million)
Table 92. Novartis Recent Development
Table 93. Amgen Company Details
Table 94. Amgen Business Overview
Table 95. Amgen Signal Transduction Inhibitors Product
Table 96. Amgen Revenue in Signal Transduction Inhibitors Business (2016-2021) & (US$ Million)
Table 97. Amgen Recent Development
Table 98. Pfizer Company Details
Table 99. Pfizer Business Overview
Table 100. Pfizer Signal Transduction Inhibitors Product
Table 101. Pfizer Revenue in Signal Transduction Inhibitors Business (2016-2021) & (US$ Million)
Table 102. Pfizer Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Signal Transduction Inhibitors Market Share by Type: 2020 VS 2027
Figure 2. Dasatinib Features
Figure 3. Erlotinib Features
Figure 4. Gefitinib Features
Figure 5. Imatinib Features
Figure 6. Lapatinib Features
Figure 7. Nilotinib Features
Figure 8. Pazopanib Features
Figure 9. Sorafenib Features
Figure 10. Sunitinib Features
Figure 11. Global Signal Transduction Inhibitors Market Share by Application: 2020 VS 2027
Figure 12. Hospital Pharmacies Case Studies
Figure 13. Retail Pharmacies Case Studies
Figure 14. Signal Transduction Inhibitors Report Years Considered
Figure 15. Global Signal Transduction Inhibitors Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 16. Global Signal Transduction Inhibitors Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Signal Transduction Inhibitors Market Share by Regions: 2020 VS 2027
Figure 18. Global Signal Transduction Inhibitors Market Share by Regions (2022-2027)
Figure 19. Global Signal Transduction Inhibitors Market Share by Players in 2020
Figure 20. Global Top Signal Transduction Inhibitors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Signal Transduction Inhibitors as of 2020
Figure 21. The Top 10 and 5 Players Market Share by Signal Transduction Inhibitors Revenue in 2020
Figure 22. Global Signal Transduction Inhibitors Revenue Market Share by Type (2016-2021)
Figure 23. Global Signal Transduction Inhibitors Revenue Market Share by Type (2022-2027)
Figure 24. North America Signal Transduction Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. North America Signal Transduction Inhibitors Market Share by Type (2016-2027)
Figure 26. North America Signal Transduction Inhibitors Market Share by Application (2016-2027)
Figure 27. North America Signal Transduction Inhibitors Market Share by Country (2016-2027)
Figure 28. United States Signal Transduction Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Canada Signal Transduction Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Signal Transduction Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Signal Transduction Inhibitors Market Share by Type (2016-2027)
Figure 32. Europe Signal Transduction Inhibitors Market Share by Application (2016-2027)
Figure 33. Europe Signal Transduction Inhibitors Market Share by Country (2016-2027)
Figure 34. Germany Signal Transduction Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. France Signal Transduction Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. U.K. Signal Transduction Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Italy Signal Transduction Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Russia Signal Transduction Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Nordic Signal Transduction Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Signal Transduction Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Signal Transduction Inhibitors Market Share by Type (2016-2027)
Figure 42. Asia-Pacific Signal Transduction Inhibitors Market Share by Application (2016-2027)
Figure 43. Asia-Pacific Signal Transduction Inhibitors Market Share by Region (2016-2027)
Figure 44. China Signal Transduction Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Japan Signal Transduction Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. South Korea Signal Transduction Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Southeast Asia Signal Transduction Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. India Signal Transduction Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Australia Signal Transduction Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Signal Transduction Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Signal Transduction Inhibitors Market Share by Type (2016-2027)
Figure 52. Latin America Signal Transduction Inhibitors Market Share by Application (2016-2027)
Figure 53. Latin America Signal Transduction Inhibitors Market Share by Country (2016-2027)
Figure 54. Mexico Signal Transduction Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Brazil Signal Transduction Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Signal Transduction Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Signal Transduction Inhibitors Market Share by Type (2016-2027)
Figure 58. Middle East & Africa Signal Transduction Inhibitors Market Share by Application (2016-2027)
Figure 59. Middle East & Africa Signal Transduction Inhibitors Market Share by Country (2016-2027)
Figure 60. Turkey Signal Transduction Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Saudi Arabia Signal Transduction Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. UAE Signal Transduction Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Bristol-Myers Squibb Revenue Growth Rate in Signal Transduction Inhibitors Business (2016-2021)
Figure 64. Roche Revenue Growth Rate in Signal Transduction Inhibitors Business (2016-2021)
Figure 65. AstraZeneca Revenue Growth Rate in Signal Transduction Inhibitors Business (2016-2021)
Figure 66. GSK Revenue Growth Rate in Signal Transduction Inhibitors Business (2016-2021)
Figure 67. Novartis Revenue Growth Rate in Signal Transduction Inhibitors Business (2016-2021)
Figure 68. Amgen Revenue Growth Rate in Signal Transduction Inhibitors Business (2016-2021)
Figure 69. Pfizer Revenue Growth Rate in Signal Transduction Inhibitors Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

以下、関連資料のご紹介

世界のベクトル信号発生器市場規模・現状・予測（2021年-2027年）

Global Vector Signal Generator Market Size, Status and Forecast 2021-2027
QYR2104Z5869 2021年4月 97Pages
QYResearch社発行の本調査資料では、ベクトル信号発生器のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（2 GHzベクトル信号発生器、4 GHzベクトル信号発生器、6GHzベクトル信号発生器）、用途別市場規模（通信、電子機器、自動車、工業...

世界のシグナルリピーター市場規模・現状・予測（2021年-2027年）

Global Signal Repeaters Market Size, Status and Forecast 2021-2027
QYR2104Z5235 2021年4月 95Pages
QYResearch社発行の本調査資料では、シグナルリピーターのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アナログ、デジタル）、用途別市場規模（電話、モバイル、ラジオ、光通信、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア...

世界のTNF阻害剤市場規模・現状・予測（2021年-2027年）

Global TNF Inhibitors Market Size, Status and Forecast 2021-2027
QYR2104Z5672 2021年4月 94Pages
QYResearch社発行の本調査資料では、TNF阻害剤のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（単剤療法、併用療法）、用途別市場規模（皮膚病、強直性脊椎炎、胃腸疾患、関節リウマチ、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ...

世界のアナログ・ミックスドシグナルIP市場規模・現状・予測（2021年-2027年）

Global Analog and Mixed Signal IP Market Size, Status and Forecast 2021-2027
QYR2104Z0311 2021年4月 90Pages
QYResearch社発行の本調査資料では、アナログ・ミックスドシグナルIPのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ファームIP、ハードIP）、用途別市場規模（家電、通信、自動車、工業、その他）、主要地域別市場規模（北米、アメリカ、ヨー...

世界のミックスドシグナル集積回路（IC）市場規模・現状・予測（2021年-2027年）

Global Mixed-signal Integrated Circuits (ICs) Market Size, Status and Forecast 2021-2027
QYR2104Z3825 2021年4月 92Pages
QYResearch社発行の本調査資料では、ミックスドシグナル集積回路（IC）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（デジタルIC、アナログIC）、用途別市場規模（コンピュータ、携帯電話、自動車、工業、その他）、主要地域別市場規模（北米...

世界の携帯電話シグナルブースター市場規模・現状・予測（2021年-2027年）

Global Mobile Signal Booster Market Size, Status and Forecast 2021-2027
QYR2104Z3855 2021年4月 130Pages
QYResearch社発行の本調査資料では、携帯電話シグナルブースターのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アナログ式シグナルブースター、デジタル式シグナルブースター）、用途別市場規模（人口密集領域、都市郊外、郊外・農村、その他）、主...

世界の携帯電話用信号シールド装置市場規模・現状・予測（2021年-2027年）

Global Mobile Phone Signal Shielding Device Market Size, Status and Forecast 2021-2027
QYR2104Z3848 2021年4月 95Pages
QYResearch社発行の本調査資料では、携帯電話用信号シールド装置のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（銅-ニッケル-亜鉛合金シールドカバー/フレーム、洋白シールドカバー/フレーム、ステンレス鋼シールドカバー/フレーム、SPTE ...

世界の可逆性モノアミン系抗うつ阻害剤（RIMA）市場規模・現状・予測（2021年-2027年）

Global Reversible Inhibitors of Monoamine (RIMA) Antidepressants Market Size, Status and Forecast 2021-2027
QYR2104Z5033 2021年4月 94Pages
QYResearch社発行の本調査資料では、可逆性モノアミン系抗うつ阻害剤（RIMA）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（非選択MAO-阻害剤、選択MAO-B阻害剤、非選択MAO-B阻害剤）、用途別市場規模（うつ病治療、パーキンソン...

世界のブルトン型チロシンキナーゼ（BTK）阻害剤市場規模・現状・予測（2021年-2027年）

Global Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size, Status and Forecast 2021-2027
QYR2104Z1019 2021年4月 154Pages
QYResearch社発行の本調査資料では、ブルトン型チロシンキナーゼ（BTK）阻害剤のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（不可逆阻害剤、可逆阻害剤）、用途別市場規模（慢性リンパ性白血病（cll）、濾胞性リンパ腫、マントル細胞リンパ腫...

世界のコグニティブ無線市場規模・現状・予測（2021年-2027年）

Global Cognitive Radio Market Size, Status and Forecast 2021-2027
QYR2104Z1428 2021年4月 90Pages
QYResearch社発行の本調査資料では、コグニティブ無線のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（政府・防衛、通信、輸送）、用途別市場規模（スペクトルセンシング、スペクトル分析、スペクトル割当、位置追跡、コグニティブルーティング）、主...

世界のベクトル信号発生器市場規模・現状・予測（2021年-2027年） Vector signal generator is a test and measurement equipment used for testing complex waveforms. This equipment was developed considering the emergence of new communication technologies and consists of a high-end radio-frequency (RF) signal generator with an IQ modulator. According to the report, the…
世界のシグナルリピーター市場規模・現状・予測（2021年-2027年） In telecommunications, a repeater is an electronic device that receives a signal and retransmits it. Rapid development of the telecommunication industry is the major factor spurring the growth of the signal repeater market during the forecast period. Market Analysis and Insights: Global Signal Repea…
世界のジペプチジルペプチダーゼIV（DPP-IV）阻害剤市場 2021：企業別、地域別、種類・用途別 The Dipeptidyl Peptidase IV (DPP-IV) Inhibitors market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiz…
世界のTNF阻害剤市場規模・現状・予測（2021年-2027年） TNF (tumor necrosis factor) inhibitors are anti-inflammatory drugs. TNF inhibitors help to block the TNF alpha that occurs naturally in the body and causes inflammation. TNF drugs are used to reduce inflammation and stop disease progression by targeting the tumor necrosis factor, which is an inflamm…
世界のミックスドシグナル集積回路（IC）市場規模・現状・予測（2021年-2027年） Mixed-signal integrated circuit is any integrated circuit that has both analog circuits and digital circuits on a single semiconductor die. Market Analysis and Insights: Global Mixed-signal Integrated Circuits (ICs) Market The global Mixed-signal Integrated Circuits (ICs) market size is projected to…